A Prospective Screening of HLA-B*57.01 Allelic Variant for Preventing the Hypersensivity Reaction to Abacavir: Experience from the Laboratory of Molecular Biology of the Infectious Diseases Division at the University Hospital of Salerno

Abacavir is a nucleoside reverse transcriptase inhibitor largely used as part of the antiretroviral therapy in Human Immunodeficiency Virus (HIV)-infected patients. Some individuals (2–9%) who start an abacavir treatment show an immunologic reaction indicated as hypersensitivity reaction syndrome (H...

Descripción completa

Detalles Bibliográficos
Autores principales: Senatore, C, Charlier, B, Truono, A, Punzi, R, D’Aniello, F, Boffa, N, Izzo, V, Conti, V, Russomanno, G, Manzo, V, Filippelli, A, Mazzeo, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Universitài Salerno 2014
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4309657/
https://www.ncbi.nlm.nih.gov/pubmed/25674551

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4309657/
https://www.ncbi.nlm.nih.gov/pubmed/25674551

Ejemplares similares